Assessing the Implementation of Myofascial Techniques in Patients With Accessory Nerve Damage After Oncologic Treatment (PHYSIOACCESS)

April 30, 2024 updated by: The Greater Poland Cancer Centre

Assessing the Implementation of Myofascial Techniques in Patients With Symptoms of Accessory Nerve Damage After Oncologic Treatment in the Head and Neck Regions

The majority of head and neck cancers develop locally and regionally. Therefore, to reduce the risk of metastasis, 90% of surgeries performed in the head and neck area include the removal of regional lymph nodes and delivery of radiotherapy.

As a consequence of radical surgery affecting the lymphatic system in the neck area, there exists a risk of damage to the cervical plexus branch (C1-C4) or the accessory nerve. Patients with damage to this nerve develop disability involving limitations to the head flexion, extension, and rotation, asymmetric shoulder blades, disturbed shoulder joint abduction, flexion, and external rotation (supination). Additionally, patients often suffer from pain, numbness, swelling, and body asymmetry.

Subject literature does not describe in a detailed and comprehensive way the physiotherapeutic procedures to be applied in case of a damaged accessory nerve as a complication after cancer treatment. Unfortunately, it is often related to patients' limited access to an effective therapy. Available information on the rehabilitation procedures is limited and it mostly focuses on exercise recommendations. An analysis of the subject literature does not show any information on the efficiency of applying the myofascial techniques for treating deficiencies related to the damage of the accessory nerve.

In the current project the investigators plan to assess the effectiveness of a physical therapy intervention comprising myofascial techniques as compared to a set of exercises designed for performing individually in head and neck cancer patients with accessory nerve damage after surgical head and neck cancer treatment. The primary outcome will be physiotherapeutic procedures to be applied in case of a damaged accessory nerve as a complication after cancer treatment. The secondary outcomes will include the efficiency of applying the myofascial techniques for treating deficiencies related to the damage of the accessory nerve.

Study Overview

Detailed Description

The majority of head and neck cancers develop locally and regionally. Therefore, to reduce the risk of metastasis, 90% of surgeries performed in the head and neck area, include the removal of regional lymph nodes and delivery of radiotherapy.

As a consequence of radical surgery affecting the lymphatic system in the neck area, there exists a risk of damage to the cervical plexus branch (C1-C4) or the accessory nerve. However, depending on the cancer stage, in numerous cases it is possible to successfully save bodily structures and maintain continuation of nerves.

The analysis of complications shows that about 80% of patients communicate subjective discomforts of upper limb on the side of the surgery. After surgery treatment including lymphadenectomy (lymph node dissection) in the head and neck area, 60% of patients suffer from the damage or dysfunction of the accessory nerve.

As a consequence, there are numerous symptoms limiting the normal functioning of a patient. Among the most frequent symptoms of accessory nerve damage is a muscle dysfunction on the side of the nerve damage (trapezius muscle, sternocleidomastoid muscle). As a result of the accessory nerve damage, patients develop disability due to limitations to the head flexion, extension, and rotation, asymmetric shoulder blades, disturbed shoulder joint abduction, flexion, and external rotation (supination). Additionally, patients suffer from pain, numbness, swelling, and body asymmetry. Subject literature does not describe in a detailed and comprehensive way the physiotherapeutic procedures to be applied in case of a damaged accessory nerve as a complication after cancer treatment. Unfortunately, endurance of the impairment is often related to patients' limited access to an effective therapy

Purpose of the research:

The aim of this study is to assess the effectiveness of a physical therapy intervention comprising myofascial techniques as compared to a set of exercises designed for performing individually in head and neck cancer patients with accessory nerve dysfunction after surgical head and neck cancer treatment. The study will include patients treated surgically for head and neck cancer with one-sided lymphadenectomy in the head and neck region who present with pain, restricted mobility or muscle atrophy. Recruited patients will be divided into one of two groups: the first group will receive physical therapy including myofascial techniques performed by the physical therapist three times a week for 45 minutes, and the second group will receive a specially designed set of exercises to perform at home three times a week for 45 minutes. The intervention will last six weeks and patients will be assessed before and after intervention. Patient's neuromuscular condition will be examined using surface electromyography (sEMG), pain at rest, during shoulder flexion, and on trapezius muscle palpation will be measured using Visual Analogue Scale, and quality of life will be assessed using modified Neck Dissection Impairment Index (NDII) questionnaire.

Specific aims:

  • To create an algorithm of physiotherapeutic procedures in case of the dysfunction of the accessory nerve and related complications.
  • To assess the effect of applied techniques on the mobility of the cervical section of the spine.
  • To assess the influence of the therapy on the mobility of the shoulder girdle on the post-surgery side.
  • To assess the influence of the therapy on patients' pain related discomfort.
  • To assess the feasibility of applying sEMG (surface electromyography) to verify the efficiency of the therapy.

Study Type

Interventional

Enrollment (Actual)

57

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Polska
      • Poznań, Polska, Poland, 61-866
        • Ewa Tanska

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • patients treated surgically for head and neck cancer with one-sided lymphadenectomy in the head and neck region,
  • symptoms of damage to the accessory nerve,
  • Eastern Cooperative Oncology Group (ECOG) scale 0-2,

Exclusion Criteria:

  • local recurrence,
  • distant metastases,
  • cardiorespiratory failure,
  • pain symptoms exceeding patients adaptability,
  • decline of the patient's level of functioning to 3-4 in ECOG scale.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Physical activity under supervision
The subjects receive physical therapy three times a week for 45 minutes, during a six-week period under professional supervision.

Physical therapy program comprised five parts. I. Fascial manipulation targeted three most active center of coordination - center of fusion points within head, neck, shoulder, shoulder blade, or chest - during each session, time depending on the patients' adaptability.

II. Manual mobilization of the scar area with each training session including: active myofascial stretching; manual scar mobilization by stretching perpendicularly and in parallel with the scar; soft tissue mobilization by rolling and pulling the surface tissues; myofascial relaxation by breaking through restrictions.

III. Relaxation of muscle contractures using post-isometric muscle relaxation of the scalene muscle, sternocleidomastoid muscle, and neck muscles - until the sessions provided no muscle elongation.

IV. Neuromuscular stimulation with proprioceptive neuromuscular facilitation - included scapula movement patterns, dynamic reversal, stabilizing reversal, upper extremity movement patterns.

Other Names:
  • Physical therapy program
Active Comparator: Home exercise

The subjects receive a set of exercises and a recommendation to perform them at least three times a week for 45 minutes.

To ensure compliance the subjects receive journals to record the performed exercises. Additionally subjects are contacted by phone to motivate them to exercise with adequate intensity. Furthermore the proper exercise technique is verified at periodic control visits.

Patients received a set of exercises to execute at home. The home exercise program comprised 12 exercises conducted in sequence:

  1. Symmetrical shoulder raises with retraction
  2. Rolling upper extremities using a ball
  3. Symmetrical shoulder raises
  4. Band exercises strengthening the upper girdle and arm
  5. Exercise of the shoulder joint flexors
  6. Side arm raises in supine position
  7. Lateral arm raises in supine position
  8. Head raises with rotation in supine position
  9. Side arm raises in prone position
  10. Front arm raises in prone position
  11. Rising and lowering the upper girdle in prone position
  12. Neck muscles stretches
Other Names:
  • Home exercise program

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Shoulder range of motion: flexion, measured in degrees
Time Frame: within one week pre-intervention and one week after the intervention
Shoulder range of motion: flexion, measured in degrees
within one week pre-intervention and one week after the intervention
Shoulder range of motion: abduction, measured in degrees
Time Frame: within one week pre-intervention and one week after the intervention
Shoulder range of motion: abduction, measured in degrees
within one week pre-intervention and one week after the intervention
Shoulder range of motion: extension, measured in degrees
Time Frame: within one week pre-intervention and one week after the intervention
Shoulder range of motion: extension, measured in degrees
within one week pre-intervention and one week after the intervention
Shoulder range of motion: rotation, measured in degrees
Time Frame: within one week pre-intervention and one week after the intervention
Shoulder range of motion: rotation, measured in degrees
within one week pre-intervention and one week after the intervention

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Cervical spine range of motion: cervical flexion, measured in degrees
Time Frame: within one week pre-intervention and one week after the intervention
Cervical spine range of motion: cervical flexion, measured in degrees
within one week pre-intervention and one week after the intervention
Cervical spine range of motion: cervical extension, measured in degrees
Time Frame: within one week pre-intervention and one week after the intervention
Cervical spine range of motion: cervical extension, measured in degrees
within one week pre-intervention and one week after the intervention
Cervical spine range of motion: cervical lateral flexion, measured in centimetres
Time Frame: within one week pre-intervention and one week after the intervention
Cervical spine range of motion: cervical lateral flexion, measured in centimetres
within one week pre-intervention and one week after the intervention
Cervical spine range of motion: cervical rotation, measured in centimetres
Time Frame: within one week pre-intervention and one week after the intervention
Cervical spine range of motion: cervical rotation, measured in centimetres
within one week pre-intervention and one week after the intervention
Passive skeletal muscle tone
Time Frame: within one week pre-intervention and one week after the intervention
Passive skeletal muscle tone in the upper trapezius on both sides, measured by surface electromyography (sEMG) amplitude
within one week pre-intervention and one week after the intervention
Skeletal muscle tone
Time Frame: within one week pre-intervention and one week after the intervention
Skeletal muscle tone in the upper trapezius on both sides, measured at one second of muscle activation using sEMG amplitude
within one week pre-intervention and one week after the intervention
Skeletal muscle fatigue
Time Frame: within one week pre-intervention and one week after the intervention
Skeletal muscle fatigue in the upper trapezius on both sides, measured as the difference between sEMG amplitude at one second and at the last second of muscle activation
within one week pre-intervention and one week after the intervention
Assessment of pain symptoms using Visual Analogue Scale (VAS) measured at rest, during shoulder flexion, and during trapezius muscle palpation; a single scale questionnaire, with range of points 1-10, with higher score meaning more intense pain
Time Frame: within one week pre-intervention and one week after the intervention
Assessment of pain symptoms using Visual Analogue Scale (VAS) measured at rest, during shoulder flexion, and during trapezius muscle palpation; a single scale questionnaire, with range of points 1-10, with higher score meaning more intense pain
within one week pre-intervention and one week after the intervention
Quality of life after neck dissection, scored based on the Neck Dissection Impairment Index (NDII) questionnaire, a single scale with range of points 5-50, with a higher score meaning worse quality of life
Time Frame: within one week pre-intervention and one week after the intervention
Quality of life after neck dissection, scored based on the Neck Dissection Impairment Index (NDII) questionnaire, a single scale with range of points 5-50, with a higher score meaning worse quality of life
within one week pre-intervention and one week after the intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Maciej Górecki, PhD, Greater Poland Cancer Centre

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2016

Primary Completion (Actual)

December 31, 2019

Study Completion (Actual)

December 31, 2020

Study Registration Dates

First Submitted

April 15, 2024

First Submitted That Met QC Criteria

April 30, 2024

First Posted (Actual)

May 3, 2024

Study Record Updates

Last Update Posted (Actual)

May 3, 2024

Last Update Submitted That Met QC Criteria

April 30, 2024

Last Verified

March 1, 2020

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Physical Therapy

Clinical Trials on Physical therapy - myofascial techniques

Subscribe